Full Text View
Tabular View
No Study Results Posted
Related Studies
Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), March 2007
First Received: December 20, 2005   Last Updated: February 6, 2009   History of Changes
Sponsors and Collaborators: Indiana University Melvin and Bren Simon Cancer Center
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00268502
  Purpose

RATIONALE: Studying quality of life in cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future cancer survivors.

PURPOSE: This clinical trial is studying the quality of life in African-American or Caucasian female breast cancer survivors.


Condition Intervention
Breast Cancer
Cancer-Related Problem/Condition
Fatigue
Procedure: fatigue assessment and management
Procedure: management of therapy complications
Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment
Procedure: study of socioeconomic and demographic variables

Genetics Home Reference related topics: breast cancer
MedlinePlus related topics: Breast Cancer Cancer
U.S. FDA Resources
Study Type: Observational
Official Title: Survey of the Quality of Life of Women

Further study details as provided by National Cancer Institute (NCI):

Estimated Enrollment: 195
Study Start Date: December 2005
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Compare disease-specific, generic, and global quality of life measures in African-American survivors of breast cancer with Caucasian survivors of breast cancer.
  • Compare these quality of life measures in African-American survivors of breast cancer with control group of African-American women with no history of breast cancer.

OUTLINE: Patients and healthy participants complete a battery of quality of life (QOL) questionnaires over approximately 65 minutes by mail or over the phone, including the Sexual Function Index, Functional Assessment of Cancer Therapy - Fatigue, Concerns About Recurrence Scale, and other measures of symptoms/side effects (including sleep problems), the RAND Physical Functioning -10 Scale, Center for Epidemiologic Studies - Depression Scale, assessment of family function/social support, ENRICH Marital Satisfaction Scale, Reed Spiritual Perspective Scale, assessments of coping and body image, Post-Traumatic Growth Inventory, and the Index of Well-being. Demographic, disease, treatment, and comorbidity information, as well as menstrual and gynecological history, work status and insurance history, and a measure of health care provider communication is collected using questionnaires and medical chart review.

PROJECTED ACCRUAL: A total of 195 patients and healthy participants will be accrued for this study.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:

    • African-American or Caucasian breast cancer survivor

      • Diagnosed with stage I-III breast cancer between the years of 1995-2003
      • Receiving follow up care at the Indiana University Cancer Center (IUCC), the IUCC Northside Clinic, Spring Mill Clinic, or Wishard Memorial Hospital
    • Healthy African-American

      • Acquaintance of an African-American breast cancer survivor
      • Not known to have breast cancer

PATIENT CHARACTERISTICS:

  • Female

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00268502

Locations
United States, Indiana
Indiana University Melvin and Bren Simon Cancer Center Recruiting
Indianapolis, Indiana, United States, 46202-5289
Contact: Clinical Trials Office - Indiana University Cancer Center     317-274-2552        
Sponsors and Collaborators
Indiana University Melvin and Bren Simon Cancer Center
Investigators
Study Chair: Kathleen Russell, RN, DNS Indiana University Melvin and Bren Simon Cancer Center
  More Information

Additional Information:
No publications provided

Study ID Numbers: CDR0000459904, IUMC-0209-08B, IUMC-0502-01B
Study First Received: December 20, 2005
Last Updated: February 6, 2009
ClinicalTrials.gov Identifier: NCT00268502     History of Changes
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
quality of life
fatigue
depression
spiritual concerns
sexual dysfunction and infertility
sleep disorders
stage I breast cancer
stage II breast cancer
stage IIIA breast cancer
stage IIIB breast cancer
stage IIIC breast cancer

Study placed in the following topic categories:
Signs and Symptoms
Infertility
Depression
Fatigue
Skin Diseases
Quality of Life
Sleep Disorders
Breast Neoplasms
Depressive Disorder
Breast Diseases

Additional relevant MeSH terms:
Signs and Symptoms
Neoplasms
Neoplasms by Site
Fatigue
Skin Diseases
Breast Neoplasms
Breast Diseases

ClinicalTrials.gov processed this record on May 06, 2009